Derralynn Hughes

17PUBLICATIONS
60CO-AUTHORS
Molecular targetsGeriatrics and gerontologyCardiology (incl. cardiovascular diseases)Metabolic medicineEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 17, 2026
Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review.

|Apr 14, 2026
Improvement of Bone Mineral Density in Patients with Type 1 Gaucher Disease Treated with Velaglucerase Alfa: Results from Clinical Studies.

Ari Zimran, Jaco Botha, Richard Eastell

|Feb 06, 2026
Cardiovascular Morbidity and Mortality in Fabry Disease.

Emanuele Monda, Athanasios Bakalakos, Annamaria Del Franco

|Jan 10, 2026
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension.

Peter Nordbeck, Ozlem Goker-Alpan, John A Bernat

|Nov 27, 2025
Secondary Mitochondrial Dysfunction in Gaucher Disease Type I, II and III-Review of the Experimental and Clinical Evidence.

Mollie Dewsbury, Tyler Purcell, Derralynn Hughes

|Nov 07, 2025
Stroke in Fabry Disease: Identification of Risk Factors for Stroke in a Large Single-Centre Cohort.

David Moreno-Martinez, Sara Lucas-Del-Pozo, Lucia Lavalle

Pageof 3

Frequent Collaborators

3 joint publications

Roberto Giugliani

3 joint publications

Dominique Paul Germain

3 joint publications

Uma Ramaswami

2 joint publications

Pilar Giraldo